510(k) device
Acuity 200 (fluoroxyfocon A) Rigid Gas Permeable Contact Lens
Acuity Polymers, Inc. · Lens, Contact (Other Material) - Daily (HQD, Class II) · First FDA decision Sep 8, 2020, newest Apr 3, 2024Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
1
Naming "200 Rigid Gas"
MAUDE reports
0
Brand "200 Rigid Gas", since 2015
PubMed studies
0
Mentioning "200 Rigid Gas"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Acuity 200 (fluoroxyfocon A) Rigid Gas Permeable Contact Lens
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K240618 · Decided Apr 3, 2024 · 29 days after receipt
Device type: Lens, Contact (Other Material) - Daily (HQD) · Ophthalmology
K203571 · Decided Apr 9, 2021 · 123 days after receipt
Device type: Lens, Contact (Other Material) - Daily (HQD) · Ophthalmology
K201194 · Decided Sep 8, 2020 · 127 days after receipt
Device type: Lens, Contact (Other Material) - Daily (HQD) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "200 Rigid Gas", any status and sponsor, newest update first.
Acuity Polymers, Inc.Not on our public-company list
NCT03971227 · 74 participants · Start Apr 1, 2019 · Primary completion Mar 19, 2020
Device: Acuity 200 (Fluoroxyfocon A) contact lens; Acuity 100 (Hexafocon A) contact lens · For: Refractive Errors
Sites: Honolulu, Hawaii; Edina, Minnesota; Pittsford, New York
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "200 Rigid Gas", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code HQD
37 reports: 3 malfunction, 34 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "200 Rigid Gas"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code HQD.
- Menicon Sf-P (Tm)Menicon Co, Ltd. · PMA 2000
- OPTIMUM GP (roflufocon D, roflurocon E) Daily Wear Contact LensContamac, Ltd. · 510(k) 2018
- Synergeyes Hybrid Contact Lenses - Daily Wear, Models A, M, Kc and PsSynergeyes, Inc. · 510(k) 2008
- Rigid Gas Permeable Contact Lens SolutionPolymer Technology Corp. · 510(k) 2001
- Visionary Optics Scleral Contact Lens (roflufocon D, roflufocon E, hexafocon A, hexafocon B, tisilfocon A, fluoroxyfocon A)Visionary Optics, LLC · 510(k) 2024
- Custom Stable Rigid Gas Permeable Scleral Contact LensValley Contax, Inc. · 510(k) 2022
- Acuity 18 (enflufocon A) Rigid Gas Permeable Contact LensAcuity Polymers, Inc. · 510(k) 2018
- FluoroPerm 30 & Paragon Thin (paflufocon C) RGP contact lenses with Tangible Hydra-PEGParagon Vision Sciences · 510(k) 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.